Center For Molecular Medicine Among First To Offer New FDA Approved Test To Aid In Treatment Of Prostate Cancer

The Center for Molecular Medicine (CMM) announced it is one of the first laboratories in the nation to offer a new, FDA-approved test that will aid in the treatment of metastatic prostate cancer. The CMM (http://www.cmmdx.org) is offering the CellSearch(TM) System from Veridex (http://www.veridex.

More: continued here

Filed under: Medical Devices on March 3rd, 2008